Martek Biosciences Corporation has been awarded European Patent No. EP-B-0 568 606, covering compositions and uses of blends of docosahexaenoic acid (DHA) and arachidonic acid (ARA) containing oils as additives or supplements for the human diet and infant formula. The patent covers the blending of DHA from microbial or fish oil sources with any microbial source of ARA and the inclusion of this blend in infant formula, nutritional supplements and food ingredients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This patent complements others already issued to Martek that cover the use of DHA oils and ARA oils individually in infant formulas and other products. Infant formula products with Martek’s oils are being marketed in over 60 countries around the world, after several major manufacturers obtained licences to Martek’s intellectual property. This patent is effective in 15 European countries.
The company said that DHA and ARA are fundamental building blocks of the brain. Babies fed with formula need to achieve a balance of these fatty acids as it occurs naturally in human milk
For more information please visit: www.martekbio.com
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
